And now, FreeStyle Libre 3 is now the smallest, thinnest7 and most discreet8 sensor available — all at the same affordable price9 as previous versions of the device — allowing as many people as possible living with diabetes to access and benefit from these significant advancements.
"People living with diabetes are at the center of our design process, and we made our next-generation technology even more discreet for a better user experience to make managing diabetes as easy and seamless as possible," said Jared Watkin, senior vice president, Diabetes Care, Abbott.
"Since we launched the first disposable glucose sensor in 2014, we've always believed all people with diabetes should have access to high-quality, accurate and affordable diabetes technologies," Watkin added.
How small, thin and discreet is FreeStyle Libre 3?
Where FreeStyle Libre 2 is about the size of two U.S. quarters stacked, FreeStyle Libre 3 is smaller, about the size of two U.S. pennies stacked.
That size reduction — by more than 70%10 — makes FreeStyle Libre 3 more environmentally sustainable. It uses 41% less plastic and 43% less carton paper,10 demonstrating the company's continued commitment to sustainability.
We're committed to keeping the mountain clean for the next party.
The FreeStyle Libre 3 system will be available in Europe in the coming months.
We'll keep climbing, our heads in the clouds, dreaming up new and better ways to keep the FreeStyle Libre system the world's leading glucose monitoring11 for people managing their diabetes.
References
1This product is not yet available in the U.S.
2Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
3Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.
4The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app.
5The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app.
6Alva, Shridhara, Timothy Bailey, Ronald Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes.” Journal of Diabetes Science and Technology, (September 2020). https://doi.org/10.1177/1932296820958754.
7Among patient-applied sensors. Date on file, Abbott Diabetes Care.
8Among on-body sensors. Data on file, Abbott Diabetes Care.
9Based on a comparison of list prices of the FreeStyle Libre portfolio versus competitor CGM systems available worldwide. The actual cost to patients may or may not be lower than other CGM systems, depending on local reimbursement, if any.
10Compared to other FreeStyle Libre systems; Data on file, Abbott Diabetes Care.
11Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for other leading personal use, sensor-based glucose monitoring systems.
FOLLOW ABBOTT